You searched for
We found 9 articles

An Outpatient Salvage Approach for Advanced Lymphoma Incorporating Stratification and Dose-Escalation

Aim: To assess efficacy and toxicity of 2 and 3 drug salvage regimens. Conclusions: Researchers concluded that both…

01 Jan 2013

Treatment of non-Hodgkin’s lymphoma with rituximab plus CHOP chemotherapy: 9-year follow-up

The objective of the study was to present long-term follow-up data with updated time to disease progression (TTP) and duration…

01 Jan 2013

Combination Chemotherapy With or Without Rituximab in Treating Patients With Relapsed Non-Hodgkin’s Lymphoma

Drugs used in chemotherapy use different ways to stop cancer cells from dividing so they stop growing or die. Monoclonal…

01 Jan 2013

MabThera in aggressive non-Hodgkin’s lymphoma

Study of MabThera in aggressive non-Hodgkin’s lymphoma in patients less than 60 years old halted two years early due to…

01 Jan 2013

Open label study of ONTAK (denileukin diftitox) in previously treated Cutaneous T-cell Lymphoma patients.

The purpose of this study is to provide an opportunity for patients who exhibit progressive disease while receiving placebo on…

01 Jan 2013

XK469 in Treating Patients With Advanced Solid Tumors or Lymphoma

RATIONALE: Drugs used in chemotherapy use different ways to stop cancer cells from dividing so they stop growing or die.

01 Jan 2013

Lymphoma

Lymphoma is a type of cancer which affects the lymph nodes or other components of the lymphatic system. It is…

01 Jan 2012

Survivors of childhood hodgkin’s lymphoma at higher risk of future health problems

Survivors of childhood hodgkin’s lymphoma at higher risk of future health problems

Adults who survived childhood Hodgkin’s Lymphoma should be especially vigilant about cancer and cardiovascular screenings, according to researchers from Wake…

01 Jun 2008